Growth Metrics

Omeros (OMER) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -10.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 34.98%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -7.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.00%
Dec 31, 2025 -66.52%
Sep 30, 2025 -31.21%
Jun 30, 2025 -64.98%
Mar 31, 2025 -14.13%
Dec 31, 2024 -74.90%
Sep 30, 2024 -39.07%
Jun 30, 2024 -25.07%
Mar 31, 2024 -23.14%
Dec 31, 2023 34.22%
Sep 30, 2023 33.17%
Jun 30, 2023 30.22%
Mar 31, 2023 30.10%
Dec 31, 2022 52.72%
Sep 30, 2022 62.21%
Jun 30, 2022 39.75%
Mar 31, 2022 31.25%
Dec 31, 2021 151.37%
Sep 30, 2021 36.42%
Jun 30, 2021 38.03%
Mar 31, 2021 35.38%
Dec 31, 2020 -62.07%
Sep 30, 2020 -69.56%
Jun 30, 2020 -31.92%
Mar 31, 2020 -24.34%
Dec 31, 2019 -98.48%
Sep 30, 2019 -5.12%
Jun 30, 2019 -5.16%
Mar 31, 2019 -6.05%
Dec 31, 2018 -7.82%
Sep 30, 2018 -25.68%
Jun 30, 2018 -26.59%
Mar 31, 2018 -17.34%
Dec 31, 2017 6.97%
Sep 30, 2017 24.14%
Jun 30, 2017 6.87%
Mar 31, 2017 2.01%
Dec 31, 2016 -0.91%
Sep 30, 2016 -0.35%
Jun 30, 2016 2.39%
Mar 31, 2016 -25.24%
Dec 31, 2015 -33.66%
Sep 30, 2015 -14.51%
Jun 30, 2015 -24.83%
Mar 31, 2015 -30.22%
Dec 31, 2014 -26.70%
Sep 30, 2014 -39.32%
Jun 30, 2014 -49.23%
Mar 31, 2014 -34.47%
Dec 31, 2013 -16.32%
Sep 30, 2013 -21.89%
Jun 30, 2013 -19.67%